The first patenting from Encephalogix Inc. details its development of platform that uses machine learning and AI to analyze EEG data that is typically ignored.

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the most common form of dementia, affects about 7.2 million Americans aged 65 ...

Electroencephalogram (EEG) is a method used to measure and visualize spontaneous electrical activity within the brain. Electrical impulses are the main form of signaling found within the brain; ...

Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease at CTAD 2025 Cognito Therapeutics, a clinical-stage medical device company ...

Top neurofeedback devices for 2026 boost focus and sleep with EEG tech, from Muse's billion-minute data to budget-friendly ...

Data published in Scientific Reports confirms a low-burden visual evoked potential (VEP) assessment can be employed across multiple clinical trial sites as an objective measure of neuroplastic ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...

On this episode of APS Radio, host Jim Burneka welcomes Stephanie Ryall, founder and clinical director of Right Mind Wellness Center (rightmindwellnesscenter.org). This episode focuses on how our ...